Send Inquiry

Request To Call Back

Romy 250 Mcg Injection

Name: Romy 250 Mcg Injection
Brand: Maheshwari Medical Agency
Price: 1950 INR
Availability: InStock

Price 1950 INR/ Vial

Get a Price/Quote

MOQ : 2 Vials

Romy 250 Mcg Injection Specification

Life Span
24 months from manufacturing date

Dosage Form
Injectable solution

Origin of Medicine
India

Salt Composition
Romiplostim

Brand Name
Romy

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Chronic immune thrombocytopenic purpura unresponsive to other treatments

Packaging Type
Vial, in box packaging

Drug Type
Injection

Ingredients
Romiplostim 250 mcg

Physical Form
Liquid

Function
Thrombopoietin receptor agonist for increasing platelet production

Recommended For
Patients with chronic immune thrombocytopenic purpura (ITP)

Dosage
250 Mg

Dosage Guidelines
Administer subcutaneously. Dosage to be based upon platelet counts and clinical response.

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Keep dry & cool place

Special Precaution
Monitor platelet counts regularly. Not for use in patients with myelodysplastic syndrome.

Warning
To be administered under medical supervision only

Route of Administration
Subcutaneous injection

Therapeutic Class
Hematological Agent

Prescription Required
Yes

Side Effects
Headache, fatigue, dizziness, arthralgia, insomnia, and possible risk of thromboembolism

Appearance
Clear to slightly opalescent, colorless solution

Strength
250 mcg per vial

Contraindications
Hypersensitivity to Romiplostim or any of its excipients

Marketed By
Intas Pharmaceuticals Ltd.

Romy 250 Mcg Injection Trade Information

Minimum Order Quantity
2 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About Romy 250 Mcg Injection

Order Romy 250 Mcg Injection-a venerable option for adults managing chronic immune thrombocytopenic purpura (ITP) who have shown inadequate response to other treatments. This clear to slightly opalescent, colorless solution offers an unbeatable therapeutic effect as a thrombopoietin receptor agonist, expertly formulated by Intas Pharmaceuticals Ltd. Try now-supply is ending soon. Available in a single-dose vial for subcutaneous injection, Romy requires prescription and careful medical supervision. Noteworthy safety: avoid use in those with hypersensitivity to Romiplostim or excipients. Monitor platelets routinely to ensure optimal benefit.

Innovative Features and Application Surface

Romy 250 Mcg Injection stands out with notable features, including precise vial packaging for single-use and a clear, easily administered formula. The subcutaneous route allows targeted delivery, maximizing efficacy while minimizing discomfort. Although primarily indicated for chronic ITP, its role as a thrombopoietin receptor agonist demonstrates versatility within hematological disorders. The application surface is restricted to subcutaneous tissue, ensuring optimal absorption. Always use under medical supervision, particularly for its specialized patient population.

Supply Ability, Delivery, and Payment Terms

Experience prompt arrival with every Romy 250 Mcg Injection order, fulfilled efficiently by our distribution network across India. Upon receiving your quotation request, supply capabilities assure consistent availability, meeting both routine and urgent needs. Payment terms are tailored for both traders and suppliers, ensuring a seamless transaction. Products are delivered safely in box packaging, typically within a reliable timeframe that supports patient and institutional requirements alike.

FAQ's of Romy 250 Mcg Injection:

Q: How should Romy 250 Mcg Injection be administered for maximum benefit?

A: Romy 250 Mcg Injection must be administered subcutaneously, with dosage individualized according to platelet counts and clinical response. Always ensure injection is performed by a healthcare professional under strict medical supervision for effective and safe therapeutic outcomes.

Q: What are the key precautions to be taken while using Romy 250 Mcg Injection?

A: Patients must be closely monitored through regular platelet counts, and the injection should not be used in individuals with myelodysplastic syndrome or known hypersensitivity to Romiplostim or its components.

Q: When can patients expect to receive their Romy 250 Mcg Injection after ordering?

A: Orders are processed promptly, and delivery typically occurs within the specified timeframe upon confirmation of payment and receipt of a quotation, ensuring timely availability for ongoing therapy.

Q: Where should Romy 250 Mcg Injection be stored to maintain its efficacy?

A: Keep the vial in a dry and cool place, away from direct sunlight. Proper storage is crucial to maintain the integrity and effectiveness of the medicine until its 24-month expiry date.

Q: What are the possible side effects associated with Romy 250 Mcg Injection?

A: Common side effects may include headache, fatigue, dizziness, arthralgia, and insomnia. In some cases, there is a risk of thromboembolism, so immediate medical attention is advised if symptoms worsen.

Q: What makes Romy 250 Mcg Injection noteworthy for hematological use?

A: Romy is notable for its targeted action as a thrombopoietin receptor agonist, helping to increase platelet production in adults with chronic ITP who have not responded to standard therapies.

Tell us about your requirement